Ignite Creation Date:
2024-05-06 @ 4:13 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04917042
Status:
RECRUITING
Last Update Posted:
2024-03-29
First Post:
2021-06-01
Brief Title:
Tazemetostat in Malignant Peripheral Nerve Sheath Tumors
Sponsor:
University of Florida
Organization:
University of Florida
Study Overview
Official Title:
Phase 2 Study Using Tazemetostat in Patients With RecurrentRefractory andor Metastatic Malignant Peripheral Nerve Sheath Tumors MPNST
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This phase 2 open label single arm study will investigate the use of tazemetostat in patients with recurrentrefractory andor metastatic malignant peripheral nerve sheath tumors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| IRB202100865 | OTHER | None | None |
| OCR40197 | OTHER | University of Florida | None |